FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/02/062824 [Registered on: 19/02/2024] Trial Registered Prospectively
Last Modified On: 16/02/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Preventive 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   fever with low blood cell (neutrophil) count 
Scientific Title of Study   Effect of nurse directed intervention (NDI) on prevention of febrile neutropenia among selected cancer patients receiving chemotherapy in a tertiary care center in Bhubaneswar. 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Anjali 
Designation  Msc Nursing Student 
Affiliation  AIIMS Bhubaneswar 
Address  College of Nursing, AIIMS Bhubaneswar, Sijua, Patrapada, Odisha
College of Nursing, AIIMS Bhubaneswar, Sijua, Patrapada, Odisha
Khordha
ORISSA
751019
India 
Phone  9870360139  
Fax    
Email  anj301k@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mariamma V George 
Designation  Associate Professor 
Affiliation  AIIMS Bhubaneswar 
Address  College of Nursing, AIIMS Bhubaneswar, Sijua, Patrapada, Odisha
College of Nursing, AIIMS Bhubaneswar, Sijua, Patrapada, Odisha
Khordha
ORISSA
751019
India 
Phone  9924861579  
Fax    
Email  nurs_mariamma@aiimsbhubaneswar.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dr Mariamma V George 
Designation  Associate Professor  
Affiliation  AIIMS Bhubaneswar 
Address  College of Nursing, AIIMS Bhubaneswar, Sijua, Patrapada, Odisha
College of Nursing, AIIMS Bhubaneswar, Sijua, Patrapada, Odisha
Khordha
ORISSA
751019
India 
Phone  9870360139  
Fax    
Email  nurs_mariamma@aiimsbhubaneswar.edu.in  
 
Source of Monetary or Material Support  
Post graduate thesis, investigation was done, investigator is following up the routine investigation done for the patients, undergoing chemotherapy in selected outpatient departments of AIIMS Bhubneswar, so their is no budgetary expenditure in this study, the that will be collected by the investigator 
 
Primary Sponsor  
Name  Anjali 
Address  College of Nursing, AIIMS Bhubaneswar, sijua, Patrapada, Odisha, 751019 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
Dr Mariamma V George  College of Nursing, AIIMS Bhubaneswar 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mariamma V George  AIIMS Bhubaneswar  1. G Block, Medical oncology Daycare 2. H Block, Radiation Oncology daycare 3. First floor, Block A, Room no. 115, 116, 117.118 Heametology Daycare 4. First Floor, I Block Medical oncology Ward
Khordha
ORISSA 
9924861579

nurs_mariamma@aiimsbhubaneswar.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, AIIMS Bhubaneswar  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C00-D49||Neoplasms,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nurse- Directed intervention for prevention of febrile Neutropenia  This will be 30-minute teaching session with an information booklet on the prevention of febrile neutropenia. This will cover topics of personal hygiene, food hygiene, environmental and hand hygiene, and there will be a reinforcement session of 10 minutes on subsequent follow-up. 
Comparator Agent  Routine care  This will be no teaching session with an information booklet on the prevention of febrile neutropenia.  
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. Aged 15 or above
2. Diagnosed with selected cancer and receiving chemotherapy
3. Able to speak and understand Hindi or Odia
4. Patients who are due for at least 4 months of chemotherapy 
 
ExclusionCriteria 
Details  1. In-patient
2. Visual or hearing impaired;
3. Known cognitive impairment;
4. Known psychiatric illness,
5. Eastern Cooperative Oncology Group (ECOG) performance status score greater than two. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Incidence Febrile Neutropenia   After 14/21 days (In 1st , 2nd and 3rd follow-up) 
 
Secondary Outcome  
Outcome  TimePoints 
Knowledge, Self-care practice and Hand-wash competency  3rd follow-up or After the 2 months of intervention 
 
Target Sample Size   Total Sample Size="78"
Sample Size from India="78" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   26/02/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a Pretest-posttest control group design to assess the Effect of Nurse-Directed Intervention (NDI) on prevention of febrile neutropenia among selected cancer patients receiving chemotherapy in a tertiary care center in Bhubaneswar.
The intervention given with the information booklet consists of a 30-minute individual teaching session on the prevention of febrile neutropenia and a reinforcement session of 10 minutes on subsequent follow-up. There will be three follow-ups with gaps of 14/21 days. Post-test is conducted on the 3rd follow-up.
The primary outcome study is the incidence of febrile neutropenia, and the secondary outcome is knowledge, self-care behaviour and hand wash competency.


 
Close